AbbVie Inc. (ABBV) Class Action Lawsuit (October 2018)

Closed

25-2369 • October 9, 2018

Class Period Start

October 25, 2013

Class Period End

September 18, 2018

PSLRA Deadline

November 20, 2018

Case Allegations

10b5

Statutes of Repose

Oct 25, 2016

Country

United States

Court

Federal Court

Docket History

Aug 20, 2025

Voluntary Dismissal (opens in a new tab)

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Sep 23, 2021

Class Certification Granted (opens in a new tab)

The court has determined that a class action is the appropriate method to bring the claims by class members. Usually, when a class is certified, the judge will also affirm an individual or entity to represent the class and finalize a class definition (i.e.: who is represented in the lawsuit).

Feb 1, 2021

Motion for Class Certification (opens in a new tab)

The plaintiffs have asked the court to approve the lawsuit to proceed as a class action on behalf of a group of investors. The judge will decide whether the case meets the requirements for class certification and which investors and claims may be included.

Sep 1, 2020

Motion to Dismiss Denied (opens in a new tab)

The court has denied the defendants' request to dismiss the lawsuit. The case can now move forward to the next stage of litigation.

Sep 20, 2019

Motion to Dismiss (opens in a new tab)

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Jul 22, 2019

First Amended Complaint (opens in a new tab)

A new complaint has been filed on behalf of certain investors in AbbVie Inc.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

May 13, 2019

Appointment of Lead Plaintiff (opens in a new tab)

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Oct 9, 2018

First Filed Complaint (opens in a new tab)

A securities fraud class action complaint has been filed on behalf of certain investors in AbbVie Inc..